FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (142)Saphnelo self-administration TULIP-SC trial demonstrates statistically significant and clinically meaningful reduction in SLE disease activity
Preheader (150)Saphnelo self-administration TULIP-SC trial demonstrates statistically significant and clinically meaningful reduction in systemic lupus erythematosus
Typography
Arial
Colors
Text Analysis
Body Words127
Subject Words15
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px760 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeAfternoon

Saphnelo self-administration TULIP-SC trial demonstrates statistically significant and clinically meaningful reduction in SLE disease activity

Saphnelo self-administration TULIP-SC trial demonstrates statistically significant and clinically meaningful reduction in systemic lupus erythematosus
Saphnelo self-administration TULIP-SC trial demonstrates statistically significant and clinically meaningful reduction in SLE disease activity